Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
Anxiolytic Drugs: Overview01:26

Anxiolytic Drugs: Overview

Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
Anxiolytic Drugs: Benzodiazepines and Buspirone01:29

Anxiolytic Drugs: Benzodiazepines and Buspirone

Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing the Impact on Health and Productivity Outcomes of Anti-PD-(L)1 Agents to Treat Early-Stage Cancers in Italy.

Clinical drug investigation·2026
Same author

Marine-Derived Defenses Against HIV: Emerging Bioactive Molecules from the Seas.

Marine drugs·2026
Same author

Epidemiology of Injuries in Women's Rugby Sevens: A Systematic Review.

Sports (Basel, Switzerland)·2026
Same author

Social Prescribing in Portugal: Study Protocol for a Primary Care Intervention Addressing Loneliness and Well-Being.

Cureus·2026
Same author

Enablement After Consultation in Primary Healthcare: How Do Patients and Doctors Cross-Sectionally Evaluate It in Northern Portugal.

Patient preference and adherence·2026
Same author

Impact of pembrolizumab on health outcomes and productivity in earlier-stage cancers within the US Medicare population.

Journal of medical economics·2025

Related Experiment Video

Updated: Jun 1, 2026

Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet
07:05

Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet

Published on: January 3, 2017

[Medicines, anxiety and depression].

Luiz Miguel Santiago1, Maria Glória Neto, Paula Miranda

  • 1Serviços de Medicina Geral e Familiar, Centro de Saúde de Eiras, Coimbra.

Acta Medica Portuguesa
|June 2, 2011
PubMed
Summary

Patients

Area of Science:

  • Psychiatry and Mental Health
  • Pharmacology
  • Sociology

Context:

  • A study investigated patient perceptions of anxiety and depression treatments.
  • The research focused on a sample from a Central Portugal Health Centre.
  • Data was collected using a validated, anonymous questionnaire.

Purpose:

  • To understand patient opinions on anxiety, depression, and their treatments.
  • To analyze these opinions based on gender, age, and labor activity.
  • To inform individualized treatment strategies.

Summary:

  • A cross-sectional study of 281 patients revealed varied opinions on anxiety and depression medications.
  • While many believed medicines could alleviate symptoms and stress, fewer felt they could cure the conditions or improve life quality.

Related Experiment Videos

Last Updated: Jun 1, 2026

Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet
07:05

Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet

Published on: January 3, 2017

  • Significant differences in opinions were noted across age groups, gender, and professional activity levels.

    • Impact:

    • Findings highlight the need for personalized pharmacological treatment for anxiety and depression.
    • Patient perceptions influence their views on medication efficacy and role in treatment.
    • Understanding demographic differences in opinions can refine patient education and treatment approaches.